Login

Delisting Not on the Agenda" | Francis Van Eeckhout (Deceuninck) | CEO Talk | Francis Van Eeckhout - CEO of Deceuninck 00:10:00

Share On Facebook Share On Twitter

Francis Van Eeckhout is Chairman/Interim CEO at Deceuninck.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The Axiom Team expresses heartfelt gratitude for the opportunity to collaborate and work together with their partners.
00:10:00
Focuses on early-stage venture investing in mobile, marketplaces, social, infrastructure|Mitch Lasky,Partner,Benchmark
00:10:00
Alzamend Neuro is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease|Stephan Jackman , Chief Executive Officer at Alzamend Neuro
00:10:00
Balancing Long-Term Goals with Short-Term Reality: 3 Simple Strategies
00:10:00
Navigating Market Volatility: Insights on Shorting Indices and Long-Term Investing | Jeremy Grantham, co-founder , GMO LLC.
00:10:00
Exploring Kairos Minerals' Gold Exploration in the Pilbara: Interview with Terri Topping at the One-to-One Mining Investment Conference in London
00:10:00
Jim Russo on the Stockdale Paradox, Economic Challenges, and the Path to Recovery | James M. Russo , Founder , Altrius Capital Management Inc.
00:10:00
Five Questions with Jan Bredack, CEO of Veganz Group AG | Jan Bredack, CEO , Veganz Group AG.
00:10:00
Brisanet's Bold Move: Revolutionizing Internet Access with Fiber Optics in Ceará | José Roberto Nogueira ,CEO, Brisanet Participações SA.
00:10:00
Navigating the Landscape of Impact Investing: Insights from Jeremy Smith of Rede Partners LLP | Jeremy Smith - Head of Impact, Rede Partners LLP
00:10:00
An interview with Alice Melpignano, CEO of NeosVoc, on LEFONTI TV, discussing innovations and insights from Neosperience S.p.A.
00:10:00
Rosario Pingaro, CEO of Convergenze SpA SB, Speaks at the Envent Winter Conference in Milan | Rosario Pingaro, CEO, Convergenze SpA Società Benefit.

© 2017 - Neuhu+